China Pharma Holdings (CPHI)
XASE:CPHI
Total Valuation
China Pharma Holdings has a market cap or net worth of $26.33M. The enterprise value is -$161.93B.
Market Cap$26.33M
Enterprise Value-$161.93B
Share Statistics
China Pharma Holdings has 40,522,003 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,522,003
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Pharma Holdings’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee18.50K
Profits Per Employee-14.23K
Employee Count224
Asset Turnover<0.01
Inventory Turnover<0.01
Valuation Ratios
The current PE Ratio of China Pharma Holdings is ―. China Pharma Holdings’s PEG ratio is -0.00936.
PE Ratio―
PS Ratio1.25
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF471.58
Price to Operating Cash Flow17.87
PEG Ratio-0.00936
Income Statement
In the last 12 months, China Pharma Holdings had revenue of 4.14M and earned -3.19M in profits. Earnings per share was -0.74.
Revenue4.14M
Gross Profit-131.95K
Operating Income-3.09M
Pretax Income-3.19M
Net Income-3.19M
EBITDA-1.51M
Earnings Per Share (EPS)-0.74
Cash Flow
In the last 12 months, operating cash flow was 148.26K and capital expenditures -97.27K, giving a free cash flow of 50.99K billion.
Operating Cash Flow148.26K
Free Cash Flow50.99K
Free Cash Flow per Share<0.01
Dividends & Yields
China Pharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change-58.03%
50-Day Moving Average0.63
200-Day Moving Average1.37
Relative Strength Index (RSI)47.22
Average Volume (3m)41.02K
Important Dates
China Pharma Holdings upcoming earnings date is May 15, 2025, Before Open (Confirmed).
Last Earnings DateMay 16, 2024
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
China Pharma Holdings as a current ratio of 0.32, with Debt / Equity ratio of 0.81%
Current Ratio0.32
Quick Ratio0.10
Debt to Market Cap35.28K
Net Debt to EBITDA107.50K
Interest Coverage Ratio-30.27
Taxes
In the past 12 months, China Pharma Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China Pharma Holdings EV to EBITDA ratio is 107.50K, with an EV/FCF ratio of -14.71M.
EV to Sales-39.07K
EV to EBITDA107.50K
EV to Free Cash Flow-14.71M
EV to Operating Cash Flow-1.09M
Balance Sheet
China Pharma Holdings has $345.11B in cash and marketable securities with $183.18B in debt, giving a net cash position of $161.94B billion.
Cash & Marketable Securities$345.11B
Total Debt$183.18B
Net Cash$161.94B
Net Cash Per Share$4.00K
Tangible Book Value Per Share-$312.17K
Margins
Gross margin is -3.18%, with operating margin of -74.53%, and net profit margin of -76.91%.
Gross Margin-3.18%
Operating Margin-74.53%
Pretax Margin-76.91%
Net Profit Margin-76.91%
EBITDA Margin-36.35%
EBIT Margin-74.45%
Analyst Forecast
The average price target for China Pharma Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-26.92%
EPS Growth Forecast69.90%